This conversation between Health Naquin, Vice President of Government & Capital Engagement at the University City Science Center and Gregory Campbell, Managing Partner of Prosalus Capital Partners explores the importance of IP to investors, the weight investors put on patent protection of science startups, and the impact of patent waivers on the investment community.
About the University City Science Center:
The University City Science Center is Philadelphia’s premier catalyst of entrepreneurial activity, healthcare innovation, and economic growth. Established in 1963, the nonprofit has been recognized by The Brookings Institution as a best-in-class investor, mentor, and economic development partner for young technology companies. Working alongside industry partners and leading research and academic institutions across the globe, the Science Center has supported over 1,000 early-stage companies. Today, the organization advances healthcare innovation from idea to the marketplace through startup support services, allocating capital, gathering the innovation community, and building inclusive STEM pathways for Philadelphia youth and adults.
For more information visit https://sciencecenter.org.